Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
General Mills, Inc. stock logo
GIS
General Mills
$59.43
-0.5%
$59.96
$55.15
$75.90
$32.73B0.064.31 million shs714,792 shs
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
$142.59
-0.3%
$136.76
$123.84
$150.45
$47.22B0.362.13 million shs324,317 shs
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$809.27
+0.5%
$847.53
$711.40
$972.53
$766.59B0.343.30 million shs488,726 shs
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
General Mills, Inc. stock logo
GIS
General Mills
-0.20%+3.38%-1.52%-6.38%-14.87%
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
+0.60%+4.51%+0.79%+9.22%+11.13%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
-2.63%-5.71%-12.68%+4.11%+5.76%
Remove Ads
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
General Mills, Inc. stock logo
GIS
General Mills
4.7559 of 5 stars
3.13.03.32.64.12.51.9
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
4.6831 of 5 stars
2.15.05.02.54.02.51.3
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
4.7995 of 5 stars
2.45.03.34.03.32.51.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
General Mills, Inc. stock logo
GIS
General Mills
2.18
Hold$65.6910.53% Upside
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
2.14
Hold$144.851.58% Upside
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
2.85
Moderate Buy$1,009.7224.77% Upside

Current Analyst Ratings Breakdown

Latest GIS, KMB, and LLY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/28/2025
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$130.00 ➝ $140.00
3/27/2025
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$138.00 ➝ $144.00
3/24/2025
General Mills, Inc. stock logo
GIS
General Mills
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageUnderweight ➝ Underweight$53.00
3/20/2025
General Mills, Inc. stock logo
GIS
General Mills
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$62.00 ➝ $60.00
3/20/2025
General Mills, Inc. stock logo
GIS
General Mills
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$60.00 ➝ $54.00
3/20/2025
General Mills, Inc. stock logo
GIS
General Mills
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$70.00 ➝ $68.00
3/18/2025
General Mills, Inc. stock logo
GIS
General Mills
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$68.00 ➝ $65.00
3/17/2025
General Mills, Inc. stock logo
GIS
General Mills
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingSector Perform ➝ Sector Perform$70.00 ➝ $70.00
3/14/2025
General Mills, Inc. stock logo
GIS
General Mills
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$60.00 ➝ $58.00
3/11/2025
General Mills, Inc. stock logo
GIS
General Mills
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$62.00 ➝ $60.00
3/10/2025
General Mills, Inc. stock logo
GIS
General Mills
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$58.00 ➝ $62.00
(Data available from 4/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
General Mills, Inc. stock logo
GIS
General Mills
$19.64B1.67$5.70 per share10.42$17.29 per share3.44
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
$20.06B2.36$9.97 per share14.30$2.94 per share48.50
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$45.04B17.04$13.19 per share61.34$15.05 per share53.77
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
General Mills, Inc. stock logo
GIS
General Mills
$2.50B$4.5512.9113.331.9413.08%27.55%8.28%N/A
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
$2.55B$7.5518.8618.094.4612.69%201.43%14.45%4/22/2025 (Estimated)
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$10.59B$11.7169.0426.001.4023.51%85.24%16.19%5/1/2025 (Estimated)

Latest GIS, KMB, and LLY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/22/2025N/A
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
$1.91N/AN/AN/A$4.90 billionN/A
3/19/2025Q3 2025
General Mills, Inc. stock logo
GIS
General Mills
$0.96$1.00+$0.04$1.12$4.99 billion$4.84 billion
2/6/2025Q4 2024
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$5.45$5.32-$0.13$4.88$13.42 billionN/A
1/28/2025Q4 2024
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
$1.50$1.50N/A$1.34$4.87 billionN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
General Mills, Inc. stock logo
GIS
General Mills
$2.404.04%+5.42%52.75%N/A
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
$5.043.53%+2.29%66.75%54 Years
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$6.000.74%+15.21%51.24%11 Years

Latest GIS, KMB, and LLY Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
1/28/2025
General Mills, Inc. stock logo
GIS
General Mills
quarterly$0.603.89%4/10/20254/10/20255/1/2025
1/28/2025
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
quarterly$1.263.84%3/7/20253/7/20254/2/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
General Mills, Inc. stock logo
GIS
General Mills
1.32
0.92
0.67
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
7.05
0.80
0.54
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
2.00
1.15
0.97

Institutional Ownership

CompanyInstitutional Ownership
General Mills, Inc. stock logo
GIS
General Mills
75.71%
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
76.29%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
82.53%

Insider Ownership

CompanyInsider Ownership
General Mills, Inc. stock logo
GIS
General Mills
0.26%
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
0.64%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
0.13%
CompanyEmployeesShares OutstandingFree FloatOptionable
General Mills, Inc. stock logo
GIS
General Mills
32,500551.23 million549.80 millionOptionable
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
44,000331.65 million329.63 millionOptionable
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
39,000948.17 million948.08 millionOptionable

Recent News About These Companies

Hims & Hers to sell Lilly’s Zepbound

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
General Mills stock logo

General Mills NYSE:GIS

$59.43 -0.29 (-0.49%)
As of 11:29 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

General Mills, Inc. manufactures and markets branded consumer foods worldwide. The company operates through four segments: North America Retail; International; Pet; and North America Foodservice. It offers grain, ready-to-eat cereals, refrigerated yogurt, soup, meal kits, refrigerated and frozen dough products, dessert and baking mixes, bakery flour, frozen pizza and pizza snacks, snack bars, fruit and savory snacks, ice cream and frozen desserts, unbaked and fully baked frozen dough products, frozen hot snacks, ethnic meals, side dish mixes, frozen breakfast and entrees, nutrition bars, and frozen and shelf-stable vegetables. The company also manufactures and markets pet food products, including dog and cat food; and operates ice cream parlors. It markets its products under the Annie's, Betty Crocker, Bisquick, Blue Buffalo, Bugles, Cascadian Farm, Cheerios, Chex, Cinnamon Toast Crunch, Cocoa Puffs, Cookie Crisp, Dunkaroos, Edgard & Cooper, Fiber One, Fruit by the Foot, Fruit Gushers, Fruit Roll-Ups, Gardetto's, Gold Medal, Golden Grahams, Häagen-Dazs, Kitano, Kix, Lärabar, Latina, Lucky Charms, Muir Glen, Nature Valley, Nudges, Oatmeal Crisp, Old El Paso, Pillsbury, Progresso, Tastefuls, Total, Totino's , Trix, True Chews, True Solutions, Wanchai Ferry, Wheaties, Wilderness, and Yoki brands. The company sells its products to grocery stores, mass merchandisers, membership stores, natural food chains, drug, dollar and discount chains, e-commerce retailers, commercial and noncommercial foodservice distributors and operators, restaurants, convenience stores, and pet specialty stores. General Mills, Inc. was founded in 1866 and is headquartered in Minneapolis, Minnesota.

Kimberly-Clark stock logo

Kimberly-Clark NYSE:KMB

$142.59 -0.44 (-0.31%)
As of 11:29 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company's Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names. Its Consumer Tissue segment provides facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve, and other brand names. The company's K-C Professional segment offers wipers, tissues, towels, apparel, personal protective equipment, soaps, and sanitizers under the Kleenex, Scott, WypAll, Kimtech, and KleenGuard brands. It also sells household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce; and away-from-home use products directly to distributors, manufacturing, lodging, office building, food service, and public facilities, as well as through e-commerce. Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.

Eli Lilly and Company stock logo

Eli Lilly and Company NYSE:LLY

$809.27 +4.04 (+0.50%)
As of 11:29 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. Further, it provides Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; and Chugai Pharmaceutical Co., Ltd. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.